Validating a human model for anxiety using startle potentiated by cue and context: The effects of alprazolam, pregabalin, and diphenhydramine

Psychopharmacology

Volumn 205, Issue 1, 2009, Pages 73-84

  Baas, J M P ^a   Mol, N ^a   Kenemans, J L ^a   Prinssen, E P ^b   Niklson, I ^b,c   Xia Chen, C ^d   Broeyer, F ^d   Van Gerven, J ^d  

^a UTRECHT UNIVERSITY   (Netherlands)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c Swissmedic   (Switzerland)

^d CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

Author keywords

Alprazolam; Anxiety; Fear; Fear potentiated startle; Human model; Pregabalin

Indexed keywords

ALPRAZOLAM; DIPHENHYDRAMINE; PLACEBO; PREGABALIN;

ADULT; ANXIETY; ARTICLE; ASSOCIATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFECT; FEAR; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SHOCK; SINGLE DRUG DOSE; STARTLE REFLEX;

ACOUSTIC STIMULATION; ALPRAZOLAM; ANTI-ANXIETY AGENTS; ANXIETY; CONDITIONING, CLASSICAL; CROSS-OVER STUDIES; CUES; DIPHENHYDRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEAR; GAMMA-AMINOBUTYRIC ACID; HUMANS; REPRODUCIBILITY OF RESULTS; STARTLE REACTION;

EID: 67649429232     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1516-5     Document Type: Article

References (45)

1. JR Atack KA Wafford SJ Tye SM Cook B Sohal A Pike C Sur D Melillo L Bristow F Bromidge I Ragan J Kerby L Street R Carling JL Castro P Whiting GR Dawson RM McKernan 2006 TPA023 [7-(1, 1-dimethylethyl)-6-(2-ethyl-2H-1, 2, 4-triazol-3-ylmethoxy)-3-(2-fluor ophenyl)-1, 2, 4-triazolo[4, 3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates J Pharmacol Exp Ther 316 410 422 (Pubitemid 41832621)
2. JM Baas C Grillon KB Böcker AA Brack CA Morgan 3rd JL Kenemans MN Verbaten 2002 Benzodiazepines have no effect on fear-potentiated startle in humans Psychopharmacology (Berl) 161 233 247 (Pubitemid 34591661)
3. JM Baas JL Kenemans KB Böcker MN Verbaten 2002 Threat-induced cortical processing and startle potentiation Neuroreport 13 133 137 (Pubitemid 34102042)
4. JE Bailey SV Argyropoulos AH Kendrick DJ Nutt 2005 Behavioral and cardiovascular effects of 7.5% CO2 in human volunteers Depress Anxiety 21 18 25 (Pubitemid 40614545)
5. JE Bailey A Kendrick A Diaper JP Potokar DJ Nutt 2007 A validation of the 7.5% CO2 model of GAD using paroxetine and lorazepam in healthy volunteers J Psychopharmacol 21 42 49 (Pubitemid 46012082)
6. J Bailey A Papadopoulos K Seddon DJ Nutt 2009 A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO2 models of experimental human anxiety J Psychopharmacol 23 117 122
7. P Bitsios A Philpott RW Langley CM Bradshaw E Szabadi 1999 Comparison of the effects of diazepam on the fear-potentiated startle reflex and the fear-inhibited light reflex in man J Psychopharmacol 13 226 234 (Pubitemid 29435781)
8. TD Blumenthal BN Cuthbert DL Filion S Hackley OV Lipp A van Boxtel 2005 Committee report: guidelines for human startle eyeblink electromyographic studies Psychophysiology 42 1 15 (Pubitemid 40395410)
9. GT Blyden DJ Greenblatt JM Scavone RI Shader 1986 Pharmacokinetics of diphenhydramine and a demethylated metabolite following intravenous and oral administration J Clin Pharmacol 26 529 533 (Pubitemid 16050179)
10. KB Böcker JM Baas JL Kenemans MN Verbaten 2004 Differences in startle modulation during instructed threat and selective attention Biol Psychol 67 343 358 (Pubitemid 39036496)
11. A Bond M Lader 1974 The use of analogue scales in rating subjective feelings Br J Med Psychol 47 211 218
12. M Davis WA Falls S Campeau M Kim 1993 Fear-potentiated startle: a neural and pharmacological analysis Behav Brain Res 58 175 198 (Pubitemid 24024057)
13. M Davis RS Mansbach NR Swerdlow S Campeau DL Braff MA Geyer 1990 Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulses in rats Psychopharmacology (Berl) 102 1 4 (Pubitemid 20227519)
14. SL de Haas SJ de Visser JP van der Post M de Smet RC Schoemaker B Rijnbeek AF Cohen JM Vega NG Agrawal TV Goel RC Simpson LK Pearson S Li M Hesney MG Murphy JM van Gerven 2007 Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2, 3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers J Psychopharmacol 21 374 383 (Pubitemid 47077294)
15. SL de Haas SJ de Visser JP van der Post RC Schoemaker K van Dyck MG Murphy M de Smet LK Vessey R Ramakrishnan L Xue AF Cohen JM van Gerven 2008 Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA(A) alpha2, 3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers J Psychopharmacol 22 24 32
16. E Fries DH Hellhammer J Hellhammer 2006 Attenuation of the hypothalamic-pituitary-adrenal axis responsivity to the Trier Social Stress Test by the benzodiazepine alprazolam Psychoneuroendocrinology 31 1278 1288 (Pubitemid 44792374)
17. PD Garzone PD Kroboth 1989 Pharmacokinetics of the newer benzodiazepines Clin Pharmacokinet 16 337 364 (Pubitemid 19167715)
18. FG Graeff A Parente CM Del-Ben FS Guimarães 2003 Pharmacology of human experimental anxiety Braz J Med Biol Res 36 421 432 (Pubitemid 36592145)
19. SJ Graham JC Scaife RW Langley CM Bradshaw E Szabadi L Xi T Crumley N Calder K Gottesdiener JA Wagner 2005 Effects of lorazepam on fear-potentiated startle responses in man J Psychopharmacol 19 249 258 (Pubitemid 40694943)
20. C Grillon 2002 Startle reactivity and anxiety disorders: aversive conditioning, context, and neurobiology Biol Psychiatry 52 958 975 (Pubitemid 35356354)
21. C Grillon 2008 Models and mechanisms of anxiety: evidence from startle studies Psychopharmacology (Berl) 199 421 437
22. C Grillon JM Baas 2002 Comments on the use of the startle reflex in psychopharmacological challenges: impact of baseline startle on measurement of fear-potentiated startle Psychopharmacology (Berl) 164 236 238 (Pubitemid 36015590)
23. C Grillon JM Baas 2003 A review of the modulation of the startle reflex by affective states and its application in psychiatry Clin Neurophysiol 114 1557 1579 (Pubitemid 37025791)
24. C Grillon R Ameli SW Woods K Merikangas M Davis 1991 Fear-potentiated startle in humans: effects of anticipatory anxiety on the acoustic blink reflex Psychophysiology 28 588 595
25. C Grillon R Ameli K Merikangas SW Woods M Davis 1993 Measuring the time course of anticipatory anxiety using the fear-potentiated startle reflex Psychophysiology 30 340 346 (Pubitemid 23184739)
26. C Grillon J Cordova LR Levine CA Morgan 3rd 2003 Anxiolytic effects of a novel group II metabotropic glutamate receptor agonist (LY354740) in the fear-potentiated startle paradigm in humans Psychopharmacology (Berl) 168 446 454 (Pubitemid 36994028)
27. C Grillon JM Baas S Lissek K Smith J Milstein 2004 Anxious responses to predictable and unpredictable aversive events Behav Neurosci 118 916 924 (Pubitemid 39346497)
28. C Grillon JM Baas DS Pine S Lissek M Lawley V Ellis J Levine 2006 The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle Biol Psychiatry 60 760 766 (Pubitemid 44427760)
29. C Grillon J Levenson DS Pine 2007 A single dose of the selective serotonin reuptake inhibitor citalopram exacerbates anxiety in humans: a fear-potentiated startle study Neuropsychopharmacology 32 225 231 (Pubitemid 44967801)
30. JS Hellewell FS Guimaraes M Wang JF Deakin 1999 Comparison of buspirone with diazepam and fluvoxamine on aversive classical conditioning in humans J Psychopharmacol 13 122 127 (Pubitemid 29276821)
31. EJ Hermans P Putman JM Baas HP Koppeschaar J van Honk 2006 A single administration of testosterone reduces fear-potentiated startle in humans Biol Psychiatry 59 872 874
32. Klumpers F, van Gerven JM, Prinssen EPM, Niklson I, Roesch F, Riedel WJ, Kenemans JL, Baas JMP (2009) Method development studies for repeatedly measuring anxiolytic drug effects in healthy humans. J Psychopharmacol doi: 10.1177/0269881109103115
33. K Low F Crestani R Keist D Benke I Brunig JA Benson JM Fritschy T Rulicke H Bluethmann H Mohler U Rudolph 2000 Molecular and neuronal substrate for the selective attenuation of anxiety Science 290 131 134 (Pubitemid 30752085)
34. N Mol JM Baas C Grillon L van Ooijen JL Kenemans 2007 Startle potentiation in rapidly alternating conditions of high and low predictability of threat Biol Psychol 76 43 51 (Pubitemid 47268627)
35. Papadopoulos A, Rich A, Nutt DJ, Bailey JE (2008) The effects of single dose anxiolytic medication on the CO2 models of anxiety: differentiation of subjective and objective measures. J Psychopharmacol doi: 10.1177/ 0269881108097716
36. DM Paton DR Webster 1985 Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines) Clin Pharmacokinet 10 477 497
37. CJ Patrick BD Berthot JD Moore 1996 Diazepam blocks fear-potentiated startle in humans J Abnorm Psychol 105 89 96 (Pubitemid 26039294)
38. J Riba A Rodriguez-Fornells G Urbano R Antonijoan MJ Barbanoj 1999 Fear potentiated startle of the acoustic startle response is preserved after lorazepam administration to human subjects Psychophysiology 36 S94
39. J Riba A Rodriguez-Fornells G Urbano A Morte R Antonijoan MJ Barbanoj 2001 Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study Psychopharmacology (Berl) 157 358 367 (Pubitemid 32988482)
40. U Rudolph F Crestani D Benke I Brunig JA Benson JM Fritschy JR Martin H Bluethmann H Mohler 1999 Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes Nature 401 796 800
41. JC Scaife RW Langley CM Bradshaw E Szabadi 2005 Diazepam suppresses the acquisition but not the expression of 'fear-potentiation' of the acoustic startle response in man J Psychopharmacol 19 347 356 (Pubitemid 41003130)
42. Spielberger CD (1972) Manual for the State-Trait Anxiety Inventory. Consulting Psychologist Press, Washington
43. SM Stahl 2004 Mechanism of action of alpha2delta ligands: voltage sensitive calcium channel (VSCC) modulators J Clin Psychiatry 65 1033 1034
44. DL Walker DJ Toufexis M Davis 2003 Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety Eur J Pharmacol 463 199 216 (Pubitemid 36205081)
45. G Zareba 2005 Pregabalin: a new agent for the treatment of neuropathic pain Drugs Today 41 509 516 (Pubitemid 41503805)